Challenges of C1-inhibitor concentrate self-administration.
Int Arch Allergy Immunol
; 161 Suppl 1: 21-5, 2013.
Article
en En
| MEDLINE
| ID: mdl-23689241
ABSTRACT
Self-administration of therapy can help hereditary angioedema (HAE) patients regain control of their disease or reduce its impact and improve the quality of their lives. However, data from a self-administration survey, and subsequent discussion at an international HAE expert meeting, identified several barriers to self-administration therapy. These barriers include difficulty in administration technique, availability of nursing resources and the mental capacity of the patient. Encouragingly, international HAE experts identified that once a patient has acquired self-administration skills, they generally retain them in the long-term. As patient uptake increases, it was recommended that follow-up management plans should be established to address any issues from the patient's perspective.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Proteína Inhibidora del Complemento C1
/
Angioedemas Hereditarios
Tipo de estudio:
Qualitative_research
Límite:
Humans
Idioma:
En
Año:
2013
Tipo del documento:
Article